{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:17Z","timestamp":1786997897264,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.03.074","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T07:24:50Z","timestamp":1680852290000},"page":"2976-2981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up study"],"prefix":"10.1016","volume":"41","author":[{"given":"Mohamad","family":"Hamad Saied","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joeri W.","family":"van Straalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sytze","family":"de Roock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrie C.J.","family":"de Joode-Smink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-2822","authenticated-orcid":false,"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-5562","authenticated-orcid":false,"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2023.03.074_b0005","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat Rev Dis Prim"},{"issue":"9563","key":"10.1016\/j.vaccine.2023.03.074_b0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.074_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-021-00629-8","article-title":"Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches","volume":"19","author":"Zaripova","year":"2021","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.vaccine.2023.03.074_b0020","doi-asserted-by":"crossref","unstructured":"Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries. 2018; 1\u201311. Available from: https:\/\/doi.org\/10.1186\/s13075-018-1780-z.","DOI":"10.1186\/s13075-018-1780-z"},{"issue":"1759\u20134804 (Electronic)","key":"10.1016\/j.vaccine.2023.03.074_b0025","first-page":"561","article-title":"The safety profile of biologic therapies for juvenile idiopathic arthritis","volume":"6","author":"Hashkes","year":"2010","journal-title":"NatRevRheumatol"},{"key":"10.1016\/j.vaccine.2023.03.074_b0030","doi-asserted-by":"crossref","unstructured":"Keller M, Pittet LF, Zimmermann P. Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment \u2014 a systematic review [Internet]. Vol. 181, European Journal of Pediatrics. Springer Berlin Heidelberg; 2022. 1329\u20131362 p. Available from: https:\/\/doi.org\/10.1007\/s00431-021-04283-w","DOI":"10.1007\/s00431-021-04283-w"},{"issue":"21","key":"10.1016\/j.vaccine.2023.03.074_b0035","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.vaccine.2017.04.015","article-title":"Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment","volume":"35","author":"Groot","year":"2017","journal-title":"Vaccine [Internet]"},{"issue":"10","key":"10.1016\/j.vaccine.2023.03.074_b0040","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2023.03.074_b0045","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: A randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2023.03.074_b0050","doi-asserted-by":"crossref","unstructured":"Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, et al. EULAR\/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis 2022; annrheumdis-2022-222574.","DOI":"10.1136\/annrheumdis-2022-222574"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.074_b0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.vaccine.2023.03.074_b0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1536867X0900900208","article-title":"The skillings-mack test (friedman test when there are missing data)","volume":"9","author":"Chatfleld","year":"2009","journal-title":"Stata J"},{"key":"10.1016\/j.vaccine.2023.03.074_b0065","unstructured":"Linear Mixed Models for Longitudinal Data; 2009."},{"key":"10.1016\/j.vaccine.2023.03.074_b0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2023.03.074_b0075","doi-asserted-by":"crossref","unstructured":"Arthritis Rheumatism - 2007 - Zonneveld\u2010Huijssoon - Safety and efficacy of meningococcal c vaccination in juvenile.pdf.","DOI":"10.1002\/art.22399"},{"issue":"9417","key":"10.1016\/j.vaccine.2023.03.074_b0080","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(04)16017-0","article-title":"MMR - Responding to retraction [6]","volume":"363","author":"Wakefield","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2023.03.074_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0019-5545.82529","article-title":"The MMR vaccine and autism: Sensation, refutation, retraction, and fraud","volume":"53","author":"Rao","year":"2011","journal-title":"Indian J Psychiatry"},{"issue":"12","key":"10.1016\/j.vaccine.2023.03.074_b0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14760584.2021.1875825","article-title":"Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy","volume":"19","author":"Tse","year":"2020","journal-title":"Expert Rev Vaccines [Internet]"},{"key":"10.1016\/j.vaccine.2023.03.074_b0095","doi-asserted-by":"crossref","unstructured":"Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford). 2009 Feb;48(2):144-8. doi: https:\/\/doi.org\/10.1093\/rheumatology\/ken436. Epub 2008 Dec 11. PMID: 19074187.","DOI":"10.1093\/rheumatology\/ken436"},{"issue":"9","key":"10.1016\/j.vaccine.2023.03.074_b0100","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","article-title":"Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection","volume":"38","author":"Uziel","year":"2020","journal-title":"Vaccine [Internet]"},{"issue":"July","key":"10.1016\/j.vaccine.2023.03.074_b0105","article-title":"Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR\/PRES Recommendations","volume":"10","author":"Jansen","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2023.03.074_b0110","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2006-0678","article-title":"Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine","volume":"118","author":"LeBaron","year":"2006","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2023.03.074_b0115","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/INF.0000000000001241","article-title":"Safety and immunogenicity of M-M-RII (Combination Measles-Mumps-Rubella Vaccine) in clinical trials of healthy children conducted between 1988 and 2009","volume":"35","author":"Kuter","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2023.03.074_b0120","first-page":"902","article-title":"A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity against Mumps in Young Adults","volume":"221","author":"Kaaijk","year":"2020","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.03.074_b0125","first-page":"1","article-title":"Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013","volume":"62","author":"McLean","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2023.03.074_b0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.24953\/turkjped.2017.04.001","article-title":"Current information about vaccination practice in pediatric rheumatic diseases and recommendations for future applications","volume":"59","author":"A\u00e7ar\u0131","year":"2017","journal-title":"Turk J Pediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2023.03.074_b0135","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00431-021-03997-1","article-title":"Vaccination of immune compromised children\u2014an overview for physicians","volume":"180","author":"Pittet","year":"2021","journal-title":"Eur J Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300381X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300381X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:42Z","timestamp":1759404342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2300381X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":27,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X2300381X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}